Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.50USD
8:40pm GMT
Change (% chg)

$-0.04 (-7.06%)
Prev Close
$0.54
Open
$0.52
Day's High
$0.55
Day's Low
$0.48
Volume
25,897
Avg. Vol
26,053
52-wk High
$2.75
52-wk Low
$0.48

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.16 December 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.67 2.67 2.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2 8.12 9.20 7.05 12.61
Quarter Ending Mar-19 2 10.98 11.20 10.77 --
Year Ending Dec-18 2 30.40 31.99 28.80 42.35
Year Ending Dec-19 2 50.16 53.51 46.82 50.09
Earnings (per share)
Quarter Ending Dec-18 2 -0.16 -0.12 -0.19 -0.01
Quarter Ending Mar-19 1 -0.07 -0.07 -0.07 --
Year Ending Dec-18 2 -0.62 -0.58 -0.67 -0.26
Year Ending Dec-19 2 -0.22 -0.11 -0.34 -0.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 8.30 7.04 1.27 15.25
Quarter Ending Mar-18 8.20 7.67 0.53 6.49
Quarter Ending Dec-17 9.19 7.52 1.67 18.16
Quarter Ending Sep-17 7.91 8.03 0.11 1.45
Quarter Ending Jun-17 7.97 6.60 1.36 17.10

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 8.12 8.12 8.12 8.12 12.61
Quarter Ending Mar-19 10.98 10.98 10.98 10.98 --
Year Ending Dec-18 30.40 30.40 30.40 30.40 42.35
Year Ending Dec-19 50.16 50.16 50.16 50.16 50.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings